Vor Biopharma Inc. (VOR) - Quarterly Income Statement

Home
VOR
Financials

0.9421 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	12.226	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.9	0.943	0.892	2.089	1.234	2.79	3.059	2.388	0.575	0.426	1.152	1.13	0.354	0.633	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	-0.9	-0.943	11.334	-2.089	-1.234	-2.79	-3.059	-2.388	-0.575	-0.426	-1.152	-1.13	-0.354	-0.633	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.927	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	21.823	24.322	20.897	27.606	23.897	21.915	17.062	16.875	15.333	15.28	12.693	12.925	12.97	8.941	11.33	8.142	5.975	6.171	2.964	1.568	0.834	0.834
General & Administrative Expenses Numbers are in millions	7.212	8.004	7.227	7.71	8.277	8.507	7.663	7.226	6.459	7.52	5.613	5.677	5.41	4.789	4.333	3.643	2.065	1.707	0.964	2.148	0.553	0.553
Selling & Marketing Expenses Numbers are in millions	-0.9	-0.943	-0.892	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	6.312	7.061	6.335	7.71	8.277	8.507	7.663	7.226	6.459	7.52	5.613	5.677	5.41	4.789	4.333	3.643	2.065	1.707	0.964	2.148	0.553	0.553
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	28.135	31.383	27.232	35.316	32.174	30.422	24.725	24.101	21.792	22.8	18.306	18.602	18.38	13.73	15.663	11.785	8.04	7.878	3.928	3.716	1.371	1.371
Operating Income Numbers are in millions	-29.035	-32.326	-28.124	-35.316	-32.174	-30.422	-24.725	-24.101	-21.792	-22.8	-18.306	-18.602	-18.38	-13.73	-15.663	-11.785	-8.04	-7.878	-3.928	-3.716	-1.387	-1.387
Operating Income Ratio Numbers are in millions	0	0	-2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	1.196	1.522	1.863	2.126	2.195	1.989	0.815	0.313	0.133	0.063	68.953	0.048	0.01	0.007	43.337	0	0	0.029	0.035	0.077	-0.267	-0.267
Income Before Tax Numbers are in millions	-27.839	-30.804	-26.261	-33.19	-29.979	-28.433	-23.91	-23.788	-21.659	-22.737	-18.252	-18.554	-18.37	-13.723	-15.663	-11.785	-8.04	-7.849	-3.893	-3.639	-1.654	-1.654
Income Before Tax Ratio Numbers are in millions	0	0	-2.148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0.9	0.565	1.424	3.065	-1.989	-1.011	-0.313	-0.133	-0.063	68.899	-0.756	0	-0.322	43.337	0	0	0	0.035	0.507	0.38	0.38
Net Income Numbers are in millions	-27.839	-30.804	-26.261	-33.19	-29.979	-26.444	-22.899	-23.475	-21.526	-22.674	-18.252	-18.554	-18.37	-13.723	-15.663	-11.785	-8.04	-7.849	-3.893	-4.146	-2.034	-2.034
Net Income Ratio Numbers are in millions	0	0	-2.148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.41	-0.45	-0.39	-0.49	-0.45	-0.4	-0.49	-0.62	-0.57	-0.61	-0.49	-0.5	-0.5	-0.62	-0.7	-0.97	-0.66	-0.64	-0.32	-35.74	-18.16	-18.16
EPS Diluted Numbers are in millions	-0.41	-0.45	-0.39	-0.49	-0.45	-0.4	-0.49	-0.62	-0.57	-0.61	-0.49	-0.5	-0.5	-0.62	-0.7	-0.97	-0.66	-0.64	-0.32	-35.63	-18.06	-18.06
EBITDA Numbers are in millions	-28.135	-31.383	-27.232	-35.316	-28.987	-29.585	-24.093	-23.209	-21.217	-22.374	-17.911	-18.228	-18.026	-13.419	-15.421	-11.593	-7.935	-7.812	-3.852	-3.684	-1.378	-1.378
EBITDA Ratio Numbers are in millions	0	0	-2.227	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Vor Biopharma Inc.

NASDAQ:VOR Add to watchlist

NASDAQ:VOR